Esperion Therapeutics Inc... (ESPR)
Esperion Therapeutics Max Pain By Strike
ESPR trades at $2.68, 78.7% above the near-term max pain of $1.5 expiring Sep 19, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($0.5-$6284.9), signaling increased put positioning or downside protection. Key magnetic zone at 1 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Esperion Therapeutics Max Pain By Expiry
Max pain for ESPR shows a downward trend from 6284.9 to 0.5, indicating bearish sentiment or hedging activity. The 699% spread signals divergent expectations across timeframes. Most levels below 2.68 may cap rallies. Strong magnetic level at 1 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 1.5 | -1.18 (-44.03%) |
| Oct 17, 2025 | 0.5 | -2.18 (-81.34%) |
| Dec 19, 2025 | 1 | -1.68 (-62.69%) |
| Jan 16, 2026 | 2 | -0.68 (-25.37%) |
| Mar 20, 2026 | 1 | -1.68 (-62.69%) |
| Jan 15, 2027 | 1 | -1.68 (-62.69%) |
| Jan 23, 2064 | 6284.9 | 6282.22 (234411.19%) |